NASDAQ:BTMD biote (BTMD) Stock Price, News & Analysis $5.24 +0.11 (+2.14%) (As of 10/28/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends About biote Stock (NASDAQ:BTMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get biote alerts:Sign Up Key Stats Today's Range$5.14▼$5.3250-Day Range$5.00▼$6.2852-Week Range$3.65▼$8.44Volume44,735 shsAverage Volume164,023 shsMarket Capitalization$325.07 millionP/E Ratio30.82Dividend YieldN/APrice Target$8.39Consensus RatingBuy Company Overviewbiote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.Read More… Unveiled: NVIDIA’s "Secret Royalty" Program (Ad)Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> biote Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks81st Percentile Overall ScoreBTMD MarketRank™: biote scored higher than 81% of companies evaluated by MarketBeat, and ranked 241st out of 997 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus Ratingbiote has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst Coveragebiote has received no research coverage in the past 90 days.Read more about biote's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth9.62% Earnings GrowthEarnings for biote are expected to grow by 9.62% in the coming year, from $0.52 to $0.57 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of biote is 30.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.74.Price to Earnings Ratio vs. SectorThe P/E ratio of biote is 30.82, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 119.62.Read more about biote's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.95% of the float of biote has been sold short.Short Interest Ratio / Days to Coverbiote has a short interest ratio ("days to cover") of 5.1.Change versus previous monthShort interest in biote has recently decreased by 7.32%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend Yieldbiote does not currently pay a dividend.Dividend Growthbiote does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.95% of the float of biote has been sold short.Short Interest Ratio / Days to Coverbiote has a short interest ratio ("days to cover") of 5.1.Change versus previous monthShort interest in biote has recently decreased by 7.32%, indicating that investor sentiment is improving significantly. News and Social Media3.6 / 5News Sentiment1.43 News Sentimentbiote has a news sentiment score of 1.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for biote this week, compared to 1 article on an average week.Search Interest2 people have searched for BTMD on MarketBeat in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, biote insiders have not sold or bought any company stock.Percentage Held by Insiders13.90% of the stock of biote is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 21.68% of the stock of biote is held by institutions.Read more about biote's insider trading history. Receive BTMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for biote and its competitors with MarketBeat's FREE daily newsletter. Email Address BTMD Stock News HeadlinesBiote (NASDAQ:BTMD) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comBiote Corp.September 28, 2024 | barrons.comMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.October 29, 2024 | Paradigm Press (Ad)biote Corp. (BTMD) Q2 2024 Earnings Call TranscriptAugust 10, 2024 | seekingalpha.comRoth MKM Keeps Their Buy Rating on biote (BTMD)August 9, 2024 | markets.businessinsider.comBiote Reports Second Quarter 2024 Financial ResultsAugust 9, 2024 | finance.yahoo.comHere's what to expect from biote A's earningsAugust 7, 2024 | markets.businessinsider.comBiote Schedules Second Quarter 2024 Financial Results Release and Conference CallJuly 25, 2024 | finance.yahoo.comSee More Headlines BTMD Stock Analysis - Frequently Asked Questions How have BTMD shares performed this year? biote's stock was trading at $4.94 at the start of the year. Since then, BTMD stock has increased by 6.1% and is now trading at $5.24. View the best growth stocks for 2024 here. How were biote's earnings last quarter? biote Corp. (NASDAQ:BTMD) announced its quarterly earnings data on Thursday, August, 8th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.05. The business had revenue of $49.17 million for the quarter, compared to analysts' expectations of $50.40 million. biote had a negative trailing twelve-month return on equity of 20.92% and a net margin of 3.67%. Who are biote's major shareholders? biote's top institutional shareholders include Sanders Morris Harris LLC (0.29%). Insiders that own company stock include Roystone Capital Management Lp, Mary Elizabeth Conlon, Robert Charles Peterson and Samar Jagat Kamdar. View institutional ownership trends. How do I buy shares of biote? Shares of BTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of biote own? Based on aggregate information from My MarketBeat watchlists, some other companies that biote investors own include Meta Platforms (META), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Visa (V) and Netflix (NFLX). Company Calendar Last Earnings8/08/2024Today10/29/2024Next Earnings (Estimated)11/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:BTMD CUSIPN/A CIK1819253 Webbiote.com Phone844-604-1246Fax212-616-9601Employees194Year FoundedN/APrice Target and Rating Average Stock Price Target$8.39 High Stock Price Target$9.00 Low Stock Price Target$6.55 Potential Upside/Downside+60.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$0.11 Trailing P/E Ratio30.82 Forward P/E Ratio10.08 P/E GrowthN/ANet Income$3.32 million Net Margins3.67% Pretax Margin10.27% Return on Equity-20.92% Return on Assets10.29% Debt Debt-to-Equity RatioN/A Current Ratio1.34 Quick Ratio0.92 Sales & Book Value Annual Sales$187.23 million Price / Sales1.74 Cash Flow$0.50 per share Price / Cash Flow10.45 Book Value($0.58) per share Price / Book-9.03Miscellaneous Outstanding Shares62,036,000Free Float46,682,000Market Cap$325.07 million OptionableNot Optionable Beta0.93 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (NASDAQ:BTMD) was last updated on 10/29/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk Drops Stunning Bombshell?Elon Musk just dropped a BOMBSHELL that could send shockwaves throughout the tech industry… While deliverin...Paradigm Press | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding biote Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share biote With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.